Literature DB >> 14511085

Attention deficit hyperactivity disorder, combined type: better executive function performance with longer-term psychostimulant medication.

Alasdair L A Vance1, Paul Maruff, Rebecca Barnett.   

Abstract

OBJECTIVE: Executive function deficits are evident in primary school-age children with attention deficit hyperactivity disorder, combined type (ADHD-CT) and are possibly improved by longer-term psychostimulant medication. In contrast, a substantial subgroup of children with ADHD-CT become symptomatic despite longer-term psychostimulant medication use. We investigated the hypothesis that better executive function performance is associated with the use of longer-term psychostimulant medication in primary school-age children with ADHD-CT who are again symptomatic of ADHD-CT, despite its use.
METHOD: A cross-sectional study of 40 primary school-age psychostimulant medication-naïve children with ADHD-CT, 26 with symptomatic ADHD-CT and treated with psychostimulant medication, and 26 control children without ADHD-CT was conducted. Nonverbal tasks of executive function were compared across the three groups.
RESULTS: The longer-term psychostimulant medication-treated group had a better executive function performance, despite being symptomatic for ADHD-CT, than the psychostimulant medication-naïve group.
CONCLUSION: Improved executive function may be a marker of psychostimulant medication effect in children with ADHD-CT treated in the longer term. This improvement may not correlate with that of the ADHD-CT symptoms. Longitudinal studies are required.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511085     DOI: 10.1046/j.1440-1614.2003.01238.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  6 in total

1.  Examining executive functioning in children with autism spectrum disorder, attention deficit hyperactivity disorder and typical development.

Authors:  Blythe A Corbett; Laura J Constantine; Robert Hendren; David Rocke; Sally Ozonoff
Journal:  Psychiatry Res       Date:  2009-03-12       Impact factor: 3.222

2.  Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Authors:  Sharon B Wigal; Tim Wigal; Sabrina Schuck; Matthew Brams; David Williamson; Robert B Armstrong; H Lynn Starr
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-04-13       Impact factor: 2.576

3.  Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status.

Authors:  Yu-Shu Huang; Liang-Jen Wang; Chih-Ken Chen
Journal:  BMC Psychiatry       Date:  2012-11-09       Impact factor: 3.630

4.  Executive Function in Autism: Association with ADHD and ASD Symptoms.

Authors:  Rachel R Lee; Anthony R Ward; David M Lane; Michael G Aman; Katherine A Loveland; Rosleen Mansour; Deborah A Pearson
Journal:  J Autism Dev Disord       Date:  2021-01-30

Review 5.  Multisensory integration and child neurodevelopment.

Authors:  Emmanuelle Dionne-Dostie; Natacha Paquette; Maryse Lassonde; Anne Gallagher
Journal:  Brain Sci       Date:  2015-02-11

6.  Effects of psycho-educational training and stimulant medication on visual perceptual skills in children with attention deficit hyperactivity disorder.

Authors:  Antigone S Papavasiliou; Irene Nikaina; Ioanna Rizou; Stratos Alexandrou
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.